0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Animal Blood Plasma and Derivatives Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-10L10147
Home | Market Reports | Health| Nursing
Global Animal Blood Plasma and Derivatives Market Insights Forecast to 2028
BUY CHAPTERS

Global Animal Blood Plasma and Derivatives Market Research Report 2025

Code: QYRE-Auto-10L10147
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Blood Plasma and Derivatives Market Size

The global market for Animal Blood Plasma and Derivatives was valued at US$ 1121 million in the year 2024 and is projected to reach a revised size of US$ 1520 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Animal Blood Plasma and Derivatives Market

Animal Blood Plasma and Derivatives Market

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 220%.
This report aims to provide a comprehensive presentation of the global market for Animal Blood Plasma and Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Blood Plasma and Derivatives.
The Animal Blood Plasma and Derivatives market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Blood Plasma and Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Blood Plasma and Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Animal Blood Plasma and Derivatives Market Report

Report Metric Details
Report Name Animal Blood Plasma and Derivatives Market
Accounted market size in year US$ 1121 million
Forecasted market size in 2031 US$ 1520 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Food & Beverages
  • Pharmaceuticals
  • Cosmetics
  • Feed
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, LAMPIRE Biological Laboratories, Inc., Lake Immunogenics, Inc., Rocky Mountain Biologicals Inc., ANZCO Foods Ltd., Auckland BioSciences Ltd., Bovogen Biologicals Pty Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Animal Blood Plasma and Derivatives company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Animal Blood Plasma and Derivatives Market growing?

Ans: The Animal Blood Plasma and Derivatives Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Animal Blood Plasma and Derivatives Market size in 2031?

Ans: The Animal Blood Plasma and Derivatives Market size in 2031 will be US$ 1520 million.

Who are the main players in the Animal Blood Plasma and Derivatives Market report?

Ans: The main players in the Animal Blood Plasma and Derivatives Market are Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Kraeber & Co GmbH, LAMPIRE Biological Laboratories, Inc., Lake Immunogenics, Inc., Rocky Mountain Biologicals Inc., ANZCO Foods Ltd., Auckland BioSciences Ltd., Bovogen Biologicals Pty Ltd.

What are the Application segmentation covered in the Animal Blood Plasma and Derivatives Market report?

Ans: The Applications covered in the Animal Blood Plasma and Derivatives Market report are Food & Beverages, Pharmaceuticals, Cosmetics, Feed, Others

What are the Type segmentation covered in the Animal Blood Plasma and Derivatives Market report?

Ans: The Types covered in the Animal Blood Plasma and Derivatives Market report are Immunoglobulin, Fibrinogen, Serum Albumin, Fetal Bovine Serum, Thrombin, New Born Calf Serum

Recommended Reports

Animal Health Solutions

Animal-derived Products

Pet Nutritional Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.2.6 Thrombin
1.2.7 New Born Calf Serum
1.3 Market by Application
1.3.1 Global Animal Blood Plasma and Derivatives Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Food & Beverages
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Feed
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Blood Plasma and Derivatives Market Perspective (2020-2031)
2.2 Global Animal Blood Plasma and Derivatives Growth Trends by Region
2.2.1 Global Animal Blood Plasma and Derivatives Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Animal Blood Plasma and Derivatives Historic Market Size by Region (2020-2025)
2.2.3 Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031)
2.3 Animal Blood Plasma and Derivatives Market Dynamics
2.3.1 Animal Blood Plasma and Derivatives Industry Trends
2.3.2 Animal Blood Plasma and Derivatives Market Drivers
2.3.3 Animal Blood Plasma and Derivatives Market Challenges
2.3.4 Animal Blood Plasma and Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue
3.1.1 Global Top Animal Blood Plasma and Derivatives Players by Revenue (2020-2025)
3.1.2 Global Animal Blood Plasma and Derivatives Revenue Market Share by Players (2020-2025)
3.2 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Animal Blood Plasma and Derivatives Revenue
3.4 Global Animal Blood Plasma and Derivatives Market Concentration Ratio
3.4.1 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2024
3.5 Global Key Players of Animal Blood Plasma and Derivatives Head office and Area Served
3.6 Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
3.7 Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Blood Plasma and Derivatives Breakdown Data by Type
4.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Type (2020-2025)
4.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031)
5 Animal Blood Plasma and Derivatives Breakdown Data by Application
5.1 Global Animal Blood Plasma and Derivatives Historic Market Size by Application (2020-2025)
5.2 Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Animal Blood Plasma and Derivatives Market Size (2020-2031)
6.2 North America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
6.4 North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Blood Plasma and Derivatives Market Size (2020-2031)
7.2 Europe Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
7.4 Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Blood Plasma and Derivatives Market Size (2020-2031)
8.2 Asia-Pacific Animal Blood Plasma and Derivatives Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025)
8.4 Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Blood Plasma and Derivatives Market Size (2020-2031)
9.2 Latin America Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
9.4 Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Blood Plasma and Derivatives Market Size (2020-2031)
10.2 Middle East & Africa Animal Blood Plasma and Derivatives Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025)
10.4 Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Proliant Inc.
11.1.1 Proliant Inc. Company Details
11.1.2 Proliant Inc. Business Overview
11.1.3 Proliant Inc. Animal Blood Plasma and Derivatives Introduction
11.1.4 Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Details
11.2.2 Thermo Fisher Scientific, Inc. Business Overview
11.2.3 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Introduction
11.2.4 Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Animal Blood Plasma and Derivatives Introduction
11.3.4 Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Company Details
11.4.2 Kraeber & Co GmbH Business Overview
11.4.3 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Introduction
11.4.4 Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Company Details
11.5.2 LAMPIRE Biological Laboratories, Inc. Business Overview
11.5.3 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Introduction
11.5.4 LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Company Details
11.6.2 Lake Immunogenics, Inc. Business Overview
11.6.3 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Introduction
11.6.4 Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Company Details
11.7.2 Rocky Mountain Biologicals Inc. Business Overview
11.7.3 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Introduction
11.7.4 Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Company Details
11.8.2 ANZCO Foods Ltd. Business Overview
11.8.3 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Introduction
11.8.4 ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Company Details
11.9.2 Auckland BioSciences Ltd. Business Overview
11.9.3 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Introduction
11.9.4 Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Company Details
11.10.2 Bovogen Biologicals Pty Ltd. Business Overview
11.10.3 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Introduction
11.10.4 Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025)
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunoglobulin
 Table 3. Key Players of Fibrinogen
 Table 4. Key Players of Serum Albumin
 Table 5. Key Players of Fetal Bovine Serum
 Table 6. Key Players of Thrombin
 Table 7. Key Players of New Born Calf Serum
 Table 8. Global Animal Blood Plasma and Derivatives Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Animal Blood Plasma and Derivatives Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Animal Blood Plasma and Derivatives Market Share by Region (2020-2025)
 Table 12. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Animal Blood Plasma and Derivatives Market Share by Region (2026-2031)
 Table 14. Animal Blood Plasma and Derivatives Market Trends
 Table 15. Animal Blood Plasma and Derivatives Market Drivers
 Table 16. Animal Blood Plasma and Derivatives Market Challenges
 Table 17. Animal Blood Plasma and Derivatives Market Restraints
 Table 18. Global Animal Blood Plasma and Derivatives Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Animal Blood Plasma and Derivatives Market Share by Players (2020-2025)
 Table 20. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
 Table 21. Ranking of Global Top Animal Blood Plasma and Derivatives Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Animal Blood Plasma and Derivatives Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Animal Blood Plasma and Derivatives, Headquarters and Area Served
 Table 24. Global Key Players of Animal Blood Plasma and Derivatives, Product and Application
 Table 25. Global Key Players of Animal Blood Plasma and Derivatives, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Animal Blood Plasma and Derivatives Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2020-2025)
 Table 29. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2026-2031)
 Table 31. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2020-2025)
 Table 33. Global Animal Blood Plasma and Derivatives Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2026-2031)
 Table 35. North America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Animal Blood Plasma and Derivatives Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Animal Blood Plasma and Derivatives Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Animal Blood Plasma and Derivatives Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Proliant Inc. Company Details
 Table 51. Proliant Inc. Business Overview
 Table 52. Proliant Inc. Animal Blood Plasma and Derivatives Product
 Table 53. Proliant Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 54. Proliant Inc. Recent Development
 Table 55. Thermo Fisher Scientific, Inc. Company Details
 Table 56. Thermo Fisher Scientific, Inc. Business Overview
 Table 57. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Product
 Table 58. Thermo Fisher Scientific, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 59. Thermo Fisher Scientific, Inc. Recent Development
 Table 60. Merck KGaA Company Details
 Table 61. Merck KGaA Business Overview
 Table 62. Merck KGaA Animal Blood Plasma and Derivatives Product
 Table 63. Merck KGaA Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 64. Merck KGaA Recent Development
 Table 65. Kraeber & Co GmbH Company Details
 Table 66. Kraeber & Co GmbH Business Overview
 Table 67. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Product
 Table 68. Kraeber & Co GmbH Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 69. Kraeber & Co GmbH Recent Development
 Table 70. LAMPIRE Biological Laboratories, Inc. Company Details
 Table 71. LAMPIRE Biological Laboratories, Inc. Business Overview
 Table 72. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Product
 Table 73. LAMPIRE Biological Laboratories, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 74. LAMPIRE Biological Laboratories, Inc. Recent Development
 Table 75. Lake Immunogenics, Inc. Company Details
 Table 76. Lake Immunogenics, Inc. Business Overview
 Table 77. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Product
 Table 78. Lake Immunogenics, Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 79. Lake Immunogenics, Inc. Recent Development
 Table 80. Rocky Mountain Biologicals Inc. Company Details
 Table 81. Rocky Mountain Biologicals Inc. Business Overview
 Table 82. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Product
 Table 83. Rocky Mountain Biologicals Inc. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 84. Rocky Mountain Biologicals Inc. Recent Development
 Table 85. ANZCO Foods Ltd. Company Details
 Table 86. ANZCO Foods Ltd. Business Overview
 Table 87. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Product
 Table 88. ANZCO Foods Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 89. ANZCO Foods Ltd. Recent Development
 Table 90. Auckland BioSciences Ltd. Company Details
 Table 91. Auckland BioSciences Ltd. Business Overview
 Table 92. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Product
 Table 93. Auckland BioSciences Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 94. Auckland BioSciences Ltd. Recent Development
 Table 95. Bovogen Biologicals Pty Ltd. Company Details
 Table 96. Bovogen Biologicals Pty Ltd. Business Overview
 Table 97. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Product
 Table 98. Bovogen Biologicals Pty Ltd. Revenue in Animal Blood Plasma and Derivatives Business (2020-2025) & (US$ Million)
 Table 99. Bovogen Biologicals Pty Ltd. Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Animal Blood Plasma and Derivatives Picture
 Figure 2. Global Animal Blood Plasma and Derivatives Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Animal Blood Plasma and Derivatives Market Share by Type: 2024 VS 2031
 Figure 4. Immunoglobulin Features
 Figure 5. Fibrinogen Features
 Figure 6. Serum Albumin Features
 Figure 7. Fetal Bovine Serum Features
 Figure 8. Thrombin Features
 Figure 9. New Born Calf Serum Features
 Figure 10. Global Animal Blood Plasma and Derivatives Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Animal Blood Plasma and Derivatives Market Share by Application: 2024 VS 2031
 Figure 12. Food & Beverages Case Studies
 Figure 13. Pharmaceuticals Case Studies
 Figure 14. Cosmetics Case Studies
 Figure 15. Feed Case Studies
 Figure 16. Others Case Studies
 Figure 17. Animal Blood Plasma and Derivatives Report Years Considered
 Figure 18. Global Animal Blood Plasma and Derivatives Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Animal Blood Plasma and Derivatives Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Animal Blood Plasma and Derivatives Market Share by Region: 2024 VS 2031
 Figure 21. Global Animal Blood Plasma and Derivatives Market Share by Players in 2024
 Figure 22. Global Top Animal Blood Plasma and Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma and Derivatives as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2024
 Figure 24. North America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
 Figure 26. United States Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
 Figure 30. Germany Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Animal Blood Plasma and Derivatives Market Share by Region (2020-2031)
 Figure 38. China Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
 Figure 46. Mexico Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Animal Blood Plasma and Derivatives Market Share by Country (2020-2031)
 Figure 50. Turkey Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Animal Blood Plasma and Derivatives Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Proliant Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 54. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 55. Merck KGaA Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 56. Kraeber & Co GmbH Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 57. LAMPIRE Biological Laboratories, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 58. Lake Immunogenics, Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 59. Rocky Mountain Biologicals Inc. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 60. ANZCO Foods Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 61. Auckland BioSciences Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 62. Bovogen Biologicals Pty Ltd. Revenue Growth Rate in Animal Blood Plasma and Derivatives Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart